Azure Ventures Group
Los Angeles, United States9
1M
7
3.00
0.22
- Areas of investment
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Rounds per year
- 3.00
- Follow on index
- 0.22
- Investments by industry
- Health Care (2)
- Medical Device (2)
- Medical (2)
- Financial Services (2)
- FinTech (2) Show 15 more
- Investments by region
- United States (8)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 0.22
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ripple | 01 Mar 2021 | Internet, Financial Services, FinTech, Payments, Cryptocurrency, Blockchain | Early Stage Venture | United States, California, San Francisco |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Diagonal Therapeutics , a Watertown, MA-based biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases | Sep 1, 2026 | Antibody Drug Discovery, Biotechnology, Hematology, Hepatology, Nephrology | - | 125000000 USD | MA-based biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, a Watertown |
| Allonnia | Oct 12, 2025 | Bio-ingenuity, Biotechnology, Decarbonization, Emerging Contaminants, Engineered Products, Environmental Impact Reduction, Mineral Recovery, Plastics Upcycling, Remediation Technology, Sustainable Mining, Upcycling Technology, Valorization Technology | Early stage | 20000000 USD | Boston, Massachusetts |
| Ensoma | Sep 23, 2025 | Autoimmune Disease, Cancer, DNA Editing, Genetic Disease, Genetic Medicines, Genome Engineering, Genomic Medicines, Hematopoietic Stem Cell Engineering, Immuno-oncology, Inherited Conditions, In Vivo Delivery, Sickle Cell Disease | - | 53000000 USD | Boston, Massachusetts |
| Antheia | Jun 3, 2025 | Biomanufacturing, Biomanufacturing Platform, Biosynthesis, Fermentation Technology, Pharmaceutical | - | 56000000 USD | Menlo Park, California |
| Canopy | Apr 30, 2025 | Accounting, AI, Practice Management Solution | - | 70000000 USD | Salt Lake City, Utah |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.